Know Labs Shares Promising Clinical Study Interim Results

Know Labs (KNW) has issued an update.

Know Labs, Inc. has released promising interim results from its latest clinical research study on July 11, 2024. This announcement, which could potentially impact investor sentiment and the company’s stock performance, has not been filed for regulatory purposes but could influence the market’s understanding of Know Labs’ progress and future prospects.

For a thorough assessment of KNW stock, go to TipRanks’ Stock Analysis page.